• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大量 SARS-CoV-2 刺突三聚体疫苗抗原候选物的变体特异性突变、温度和 pH 值对构象的影响。

Influence of variant-specific mutations, temperature and pH on conformations of a large set of SARS-CoV-2 spike trimer vaccine antigen candidates.

机构信息

Human Health Therapeutics Research Centre, National Research Council Canada, 6100 Royalmount Avenue, Montreal, QC, H4P 2R2, Canada.

Human Health Therapeutics Research Centre, National Research Council Canada, Ottawa, ON, Canada.

出版信息

Sci Rep. 2023 Oct 1;13(1):16498. doi: 10.1038/s41598-023-43661-2.

DOI:10.1038/s41598-023-43661-2
PMID:37779126
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10543594/
Abstract

SARS-CoV-2 subunit vaccines continue to be the focus of intense clinical development worldwide. Protein antigens in these vaccines most commonly consist of the spike ectodomain fused to a heterologous trimerization sequence, designed to mimic the compact, prefusion conformation of the spike on the virus surface. Since 2020, we have produced dozens of such constructs in CHO cells, consisting of spike variants with different mutations fused to different trimerization sequences. This set of constructs displayed notable conformational heterogeneity, with two distinct trimer species consistently detected by analytical size exclusion chromatography. A recent report showed that spike ectodomain fusion constructs can adopt an alternative trimer conformation consisting of loosely associated ectodomain protomers. Here, we applied multiple biophysical and immunological techniques to demonstrate that this alternative conformation is formed to a significant extent by several SARS-CoV-2 variant spike proteins. We have also examined the influence of temperature and pH, which can induce inter-conversion of the two forms. The substantial structural differences between these trimer types may impact their performance as vaccine antigens.

摘要

SARS-CoV-2 亚单位疫苗仍然是全球临床开发的重点。这些疫苗中的蛋白抗原最常由融合了异源三聚化序列的刺突外域组成,旨在模拟病毒表面刺突的紧凑、预融合构象。自 2020 年以来,我们已经在 CHO 细胞中生产了数十种这样的构建体,这些构建体由融合了不同三聚化序列的不同突变的刺突变体组成。这组构建体表现出明显的构象异质性,通过分析性尺寸排阻色谱法始终检测到两种不同的三聚体种类。最近的一份报告表明,刺突外域融合构建体可以采用另一种由松散结合的外域原聚体组成的三聚体构象。在这里,我们应用多种生物物理和免疫学技术证明,这种替代构象是由几种 SARS-CoV-2 变体的刺突蛋白在很大程度上形成的。我们还研究了温度和 pH 值的影响,这可能会诱导两种形式的相互转化。这两种三聚体类型之间存在显著的结构差异,可能会影响它们作为疫苗抗原的性能。

相似文献

1
Influence of variant-specific mutations, temperature and pH on conformations of a large set of SARS-CoV-2 spike trimer vaccine antigen candidates.大量 SARS-CoV-2 刺突三聚体疫苗抗原候选物的变体特异性突变、温度和 pH 值对构象的影响。
Sci Rep. 2023 Oct 1;13(1):16498. doi: 10.1038/s41598-023-43661-2.
2
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.基于 CHO 生产的、预融合 Spike 三聚体和铝佐剂/CpG 佐剂的重组 COVID-19 疫苗的开发。
Vaccine. 2021 Nov 26;39(48):7001-7011. doi: 10.1016/j.vaccine.2021.10.066. Epub 2021 Oct 30.
3
Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease.单次免疫表达刺突蛋白和核衣壳蛋白的重组 ACAM2000 痘苗病毒可保护仓鼠免受 SARS-CoV-2 引起的临床疾病。
J Virol. 2022 May 11;96(9):e0038922. doi: 10.1128/jvi.00389-22. Epub 2022 Apr 12.
4
Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines.三种原型株衍生重组蛋白疫苗对 B.1.1.7、B.1.351 和 B.1.617.1 变异 SARS-CoV-2 诱导产生广谱中和抗体。
Viruses. 2021 Jul 22;13(8):1421. doi: 10.3390/v13081421.
5
The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes.SARS-CoV-2 刺突蛋白可逆地采样开放三聚体构象,暴露出新的表位。
Nat Struct Mol Biol. 2022 Mar;29(3):229-238. doi: 10.1038/s41594-022-00735-5. Epub 2022 Mar 2.
6
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.通过 SARS-CoV-2 刺突蛋白变体逃避中和抗体。
Elife. 2020 Oct 28;9:e61312. doi: 10.7554/eLife.61312.
7
SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates.昆虫细胞表达的 SARS-CoV-2 刺突蛋白可在非人灵长类动物中引起高中和抗体滴度。
Emerg Microbes Infect. 2020 Dec;9(1):2076-2090. doi: 10.1080/22221751.2020.1821583.
8
A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera.一种产生 VFLIP-X 刺突的环状 mRNA 疫苗原型通过小鼠血清赋予了对 SARS-CoV-2 变体的广泛中和作用。
Antiviral Res. 2022 Aug;204:105370. doi: 10.1016/j.antiviral.2022.105370. Epub 2022 Jun 27.
9
Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern.调节免疫应答:硫酸化古菌糖脂古菌胞作为一种有效的疫苗佐剂,用于诱导针对 SARS-CoV-2 奥密克戎关切变异株的体液和细胞介导免疫。
Front Immunol. 2023 Apr 14;14:1182556. doi: 10.3389/fimmu.2023.1182556. eCollection 2023.
10
The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.新冠病毒-19(Sars-Cov-2)的英国变体不应造成疫苗问题。
J Biol Regul Homeost Agents. 2021 Jan-Feb;35(1):1-4. doi: 10.23812/21-3-E.

引用本文的文献

1
Modifying the glycosylation profile of SARS-CoV-2 spike-based subunit vaccines alters focusing of the humoral immune response in a mouse model.改变基于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的亚单位疫苗的糖基化模式,会改变小鼠模型中体液免疫反应的聚焦情况。
Commun Med (Lond). 2025 Apr 11;5(1):111. doi: 10.1038/s43856-025-00830-w.
2
Characterization of biotinylated human ACE2 and SARS-CoV-2 Omicron BA.4/5 spike protein reference materials.生物素化人血管紧张素转换酶 2 和 SARS-CoV-2 奥密克戎 BA.4/5 刺突蛋白参考物质的特性分析。
Anal Bioanal Chem. 2024 Sep;416(22):4861-4872. doi: 10.1007/s00216-024-05413-7. Epub 2024 Jun 28.

本文引用的文献

1
A CHO stable pool production platform for rapid clinical development of trimeric SARS-CoV-2 spike subunit vaccine antigens.一种 CHO 稳定池生产平台,用于快速临床开发三聚体 SARS-CoV-2 刺突亚单位疫苗抗原。
Biotechnol Bioeng. 2023 Jul;120(7):1746-1761. doi: 10.1002/bit.28387. Epub 2023 Mar 29.
2
A Covid-19 Milestone Attained - A Correlate of Protection for Vaccines.新冠疫情的一个里程碑达成——疫苗保护的一个相关因素。
N Engl J Med. 2022 Dec 15;387(24):2203-2206. doi: 10.1056/NEJMp2211314. Epub 2022 Dec 10.
3
Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern.
源自新冠病毒变异株贝塔和德尔塔的严重急性呼吸综合征冠状病毒2刺突抗原的免疫原性。
NPJ Vaccines. 2022 Oct 12;7(1):118. doi: 10.1038/s41541-022-00540-7.
4
Arsenal of nanobodies shows broad-spectrum neutralization against SARS-CoV-2 variants of concern in vitro and in vivo in hamster models.纳米抗体库在体外和体内仓鼠模型中显示出对 SARS-CoV-2 关切变异株的广谱中和作用。
Commun Biol. 2022 Sep 9;5(1):933. doi: 10.1038/s42003-022-03866-z.
5
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19.抗2019冠状病毒病蛋白质亚基疫苗综述
Front Microbiol. 2022 Jul 14;13:927306. doi: 10.3389/fmicb.2022.927306. eCollection 2022.
6
Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine.β佐剂重组加强疫苗的免疫原性和安全性。
N Engl J Med. 2022 Jul 28;387(4):374-376. doi: 10.1056/NEJMc2206711. Epub 2022 Jun 29.
7
A scalable serology solution for profiling humoral immune responses to SARS-CoV-2 infection and vaccination.一种可扩展的血清学检测方法,用于分析针对SARS-CoV-2感染和疫苗接种的体液免疫反应。
Clin Transl Immunology. 2022 Mar 23;11(3):e1380. doi: 10.1002/cti2.1380. eCollection 2022.
8
Characterization of a SARS-CoV-2 spike protein reference material.SARS-CoV-2 刺突蛋白标准物质的特性描述。
Anal Bioanal Chem. 2022 May;414(12):3561-3569. doi: 10.1007/s00216-022-04000-y. Epub 2022 Mar 9.
9
The SARS-CoV-2 spike reversibly samples an open-trimer conformation exposing novel epitopes.SARS-CoV-2 刺突蛋白可逆地采样开放三聚体构象,暴露出新的表位。
Nat Struct Mol Biol. 2022 Mar;29(3):229-238. doi: 10.1038/s41594-022-00735-5. Epub 2022 Mar 2.
10
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.新型冠状病毒病佐剂亚单位蛋白疫苗(SCB-2019)的有效性:一项 2 期和 3 期、多中心、双盲、随机、安慰剂对照试验。
Lancet. 2022 Jan 29;399(10323):461-472. doi: 10.1016/S0140-6736(22)00055-1. Epub 2022 Jan 20.